Formulation Development Services - China

Formulation Development Services

NDA Formulation Strategy

Suspensions (microsuspensions & nanosuspensions)

API filling into bottles (powder in bottles)

API encapsulation / vial filling using Xcelodose 120S & 600S

Dry blending and encapsulation

Liquid fill into hard gelatin capsules (enabling technology)

Spray drying (enabling technology)

Granulation (dry & wet) and encapsulation / tableting

Direct Compression

Sachets

ANDA Formulation Strategy

Select of RLD, overall profile of RLD

Formulation development by screen critical factors

Process development base on QbD

Package

Scale up and technical transfer

Stability

Life Cycle Management – New Formulation Development Support:

Enable and impart late stage NCE or “Marketed Compounds” with new product attributes

Improve safety profile

Enhance efficacy and or afford new treatments

Improve compliance and usage

Rapid onset, taste masking, new route delivery, etc.

Controlled or sustained release to reduce dosing frequency

Extend market exclusivity

Create product differentiation and enhance product performance through formulation innovation

Enable new product extension

Potential market protection through new IP generation

Enabling Formulation Technology Support:

Solubilization improvement

Micronization using air jet mill

Nanosuspension or microsuspension followed by granulation

Spray dried amorphous solid dispersion

Hot melt extrusion

Liquid filled hard gelatin capsules

Modified release tablet formulations with one or two layers

Sustained release or delayed release pellets in capsules

Company Contact:

• Posted By: Shanghai Medicilon Inc.

• Phone: +862158591500

• Address: 585 Chuanda Road,Pudong,Shanghai20129 9,China, Shanghai , Pudong New Area, China

• Email:

• Website: https://www.medicilon.com

• Business Description: Medicilon offers fully integrated pharmaceutical services for the global scientific community.
  
  We focus on providing an exceptional client-centered experience and advancing the drug discovery process.
  
  Since the founding of our company in 2004, our integrated services across biology, chemistry and preclinical services are uniquely designed to help clients developing their research and discovery programs from the initial idea stage to the IND filing phase.